Comparing the results of Table 1 with those of Table 2 , it is found that both experiments gave the same results, except doubtful cases in Table 1 . S. griseus which produced grisein-like antibiotic produced an antiviral substance to Japanese B encephalitis.
Further experiment indicated that this antiviral substance was best produced in the medium containing glucose, maltose or dextrin as carbon sources.
This substance was not transferred to ethyl acetate at both pH 7.0 and 2.0 in the extraction experiment.
S. albidofiavus which produced streptothricin A was found to produce an antiviral substance to Japanese B encephalitis. This substance seemed to be different from streptothricin A, because other streptothricin A producing strains did not produce the antiviral substance.
The substances effective to western equine encephalitis virus were found to all belong to abikoviromycin by the color test reaction, discovered by Umezawa and others (3).
But two abikoviromycin-producing strains were found' also to produce the substance effective to Japanese B encephalitis virus.
As shown in Table 3 , this effective substance was not extracted U MEZAWA et al The antiviral substance produced by the strain Z-4-1 was further studied in detail and the results are described in the following section.
It should be emphasized that all strains gave negative results when the broth filtrate was injected subcutaneously to mice which had been intracerebrally infected with the virus of Japanese B encephalitis or that of equine encephalitis. It means whether the amount (0.3ml) of the broth filtrate injected was insufficient for the protection, or the broth filtrate contained no antiviral substance effective in the protection test.
The results of present experiment seem to indicate the necessity for injecting broth filtrate as much as possible.
The injection of 0.5-1.0ml every day for 3-4 days will make the screening much more sensitive.
It is difficult to conclude at present that whether the effective substances screened by injecting the mixture of virus and broth filtrate inactivated the virus before injection or after being injected into animal bodies.
In this connection, it is interesting to note that the substance effective to Japanese B encephalitis is not effective to western equine encephalitis and vice versa, suggesting that their effect is not due to their non specific protein denaturating activity.
On the other hand, the amount of the filtrate injected into brain was only 0.015 ml and this little amount seems to indicate that the effective substance inactivated the virus before injection.
The present results indicate the necessity of screening with both methods, namely, one is the injection of the mixture of virus and broth filtrate and another is the subcutaneous injection of the filtrate or the concentrated filtrate repeated for several times to the infected mice. Moreover, since an antiviral substance is specifically effective against a group of viruses, the broth filtrate should be tested on several kinds of viruses for completeness.
On an antiviral substance, achromoviromycin
The strain Z-4-1, shown in Waksman and Henrici according to the key. But it differs from the former in the points of spiral formation, hemolysis, liquefaction of gelatin and proteolytic action of milk, and, it differs from the latter in the points of liquefaction of coagulated serum. Also it differs from any other species.
The writers, therefore, concluded that this strain belongs to a new species and proposed to name it as Streptomyces achromogenes OKAMI et Umezawa, because it produces no pigment except on synthetic agar. Since the species was named Streptomyces achromogenes, its antiviral substance was named achromoviromycin.
As shown in Table 4 , this substance was Table  4 . Shaking culture of the strain Z-4-1 which produces an antiviral substance to Japanese B encephalitis * 1 in 10 indicates the broth filtrate is diluted to 1 in 5 and mixed with the same volume of the virus suspension (10-4 dilution) and injected to mice intracerebrally. ** L6 indicates that the mouse died 6 after days injection.
S indicates that the mouse survived. *** Basal medium contains 0.5% meat extract, 0.5% peptone and 0.5% NaCl.
Carbon sources are added at 1.0%. Subcutaneous injection of 10mg slightly prolonged the survival days of the intracerebrally infected mice. Molisch, Tolens, ninhydrin, Sakaguchi, Millon, Pauli, and ferric chloride tests off the crude powder were all negative.
SUMMARY (1)
Two methods of screening antiviral substances produced by streptomyces and their results of their actual application were described.
(2)
The broth filtrates of S. griseus which produced grisein or griseinlike substance, S. albidofiavus which produced streptothricin, two strains of S.
abokoensis, and the filtrate of a strain Z-4-1 presented an antiviral effect when mixed with Japanese B. encephalitis virus and injected intracerebrally to mice.
The antiviral substance to Japanese B encephalitis produced by S.
griseus, and S. abikoensis were not extracted with ethyl acetate both at pH 2.0 and 7.0.
(4) A strain Z-4-1 was found to belong to a new species and was named Streptomyces achromogenes Okami et Umezawa. The production of an antiviral substance was observed when shaking cultured in a medium containing meat extract, peptone and dextrin, starch, or glycerol.
The antiviral substance was extracted with ethyl acetate at pH 2.0 and named achromoviromycin.
